Specific Red Cell Adherence Testing and Benign Prostatic Hyperplasia

Publisher Website
Google Scholar
Abstract
The value of specific red cell adherence testing in predicting the behavior of low grade, low stage prostatic carcinoma was evaluated by attempting to detect its presence in benign prostatic diseases. The presence of specific red cell adherence in the prostatic acini was tested in 36 consecutive [human] prostatectomy specimens of benign disease. The presence of red cell adherence was detected in only 36% of the cases with benign prostatic hyperplasia. Specific red cell adherence testing is not present in a sufficient percentage of patients with benign disease to allow its usefulness in determining the aggressive behavior of prostatic cancer.